Reply to Masters
David T. Dennis · Clinical Infectious Diseases · 2006
Not cached yet. This record was fetched live for this request and is stored after the lookup. Reopening the page should serve the cached copy.
Clinical Infectious Diseases · Oxford University Press · letter · 2006
Abstract
Sir—Dr. Masters has a large experience with tick-associated rash illness in Missouri and raises issues [1] prompting the following responses. First, Lyme disease is confirmed by establishing infection with Borrelia burgdorferi, not by satisfying a surveillance case definition, whose positive predictive value is a function of its specificity and the underlying frequency of occurrence of the disease in the population [2]. Because B. burgdorferi infection is not endemic in Missouri, erythema migrans—like lesions experienced by patients there are poorly predictive of Lyme disease.
Avoidance of false-identifications in areas where the disease is not endemic was addressed in the national Lyme disease surveillance definition, which states that “Laboratory confirmation (of EM [erythema migrans]) is recommended for persons with no known exposure” [3, p. 21]. Exposure was defined as occurring in a person having recently been in potential tick habitats in a county where Lyme disease is endemic. This underscores the need for confirmatory testing and obtaining travel histories from persons suspected of contracting Lyme disease in areas where it is not endemic.
Open the resolved locator · 10.1086/500022
Metadata licence: OpenAlex metadata (CC0)